Pharmacogenomics Corner

Back to articles

Pharmacogenomics testing is cost effective

KEY POINT

A pharmacoeconomic analysis concluded that one-time genetic testing is cost effective for preventing adverse drug reactions (ADRs) over a patient’s lifetime.

SOURCES

Alagoz O et al. Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions. Pharmacogenomics J. 2016;16:129–36.